Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Real-World Treatment Patterns and Outcomes Among Patients With Mantle Cell Lymphoma

Mayur Narkhede, MD, Division of Hematology and Oncology, Department of Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, analyzed treatment patterns among patients with mantle cell lymphoma at different lines of therapy, focusing on Bruton tyrosine kinase inhibitor use. In this study, Dr Narkhede compared outcomes with known prognostic factors using an electronic health record database.

Advertisement

Advertisement

Advertisement